Delivery Order SPE2DR25D1017-SPE2DR26F9ALK
- Not listed
- The Defense Logistics Agency awarded a $1,401.99 delivery order to AmerisourceBergen Drug Corp for Miebo 100% eye drop solution (3ml) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed price, competitively awarded contract utilizes no set-aside designation and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The place of performance is located in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order valued at $1,261.74 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on September 11, 2025, with an ultimate completion date of September 12, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,957.57 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on August 7, 2025, with an ultimate completion date of August 8, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,441.87 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitive award under the company's existing contract vehicle with DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $7,011.60 delivery order to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3 mL units) on June 2, 2025, with completion scheduled for June 3, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,378.59 delivery order on October 29, 2025, for MIEBO 100% eye drop solution (3ml). The contract represents a non-set-aside, competitively awarded delivery order with firm fixed pricing under an existing indefinite delivery contract vehicle. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, with an ultimate completion date of October 30, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $2,072.18 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ml) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed-price contract with no set-aside designation, performed at the contractor's Conshohocken, Pennsylvania location. The award represents a small-value delivery order under the company's larger pharmaceutical supply vehicle with DLA. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $8,490.73 to AmerisourceBergen Drug Corp on September 4, 2025, for MIEBO 100% eye drop solution in 3ml quantities. The contract is a firm fixed price delivery order with performance in Conshohocken, Pennsylvania, and an ultimate completion date of September 5, 2025. This award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's capability to compete for federal pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $3,817.41 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution (3ML) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed price contract represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,748.98 on November 25, 2025, for the supply of Miebo 100% eye drops (3ml). The Defense Logistics Agency (DLA) issued this competitively awarded, firm fixed-price delivery order, which is scheduled for completion by November 26, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9ALKDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,401.99 to AmerisourceBergen Drug Corp for MIEBO 100% eye drop solution in a 3 mL formulation. This firm fixed-price delivery order, issued on November 28, 2025, represents a non-competitive, non-set-aside procurement under the company's existing DLA contract vehicle. The order is scheduled for completion by December 1, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves critical federal medical supply needs for military healthcare systems and other government agencies through this comprehensive global pharmaceutical support vehicle. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of pharmaceutical products, medical devices, and healthcare commodities across multiple therapeutic domains to support the Department of Defense and other federal customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/27/25 |